Plastic Surgery Ohio - Columbus Arena District and Short North Face, Form & Function
HomeSurgeonNewsSpecialsContact UsDirectionsParking
(614) 827-6712

Non-Invasive Services:

Botox
Soft Tissue Fillers
Chemical Peels
Microdermabrasion
Hair Removal
Laser
Eyelashes

Cosmetic Surgery Procedures:
Eyelid Surgery
Brow Lift
Face Lift
Facial Implants

Columbus Ohio Arena District Website - Botox and a Movie?
Short North Arts District Website
Short North Market Website
Huntington Park Website - Home of the Columbus Clippers
The Eye Center of Columbus
Latisse for Lashes

LATISSE™ — First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes

New Prescription Product Increases Length, Thickness and Darkness of Eyelashes

The U.S. Food and Drug Administration (FDA) has approved LATISSE™ (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE™ is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.

Available only through a doctor, LATISSE™ is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. LATISSE™ users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain effect, continued treatment with LATISSE™ is required. If use of LATISSE™ is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).

Bimatoprost is the active pharmaceutical ingredient in the formulation of LATISSE™ and is a structural prostaglandin analog, a lipid compound derived from fatty acids designed to bind to prostaglandin (PG) receptors. PG receptors are present in hair, particularly in the dermal papilla and outer root sheath. Although the precise mechanism of action is unknown, PG receptors are thought to be involved in the development and regrowth of the hair follicle,i by increasing the percent of hairs in, and the duration of, the anagen or growth phase.

LATISSE™ will be available in the United States by prescription only and is subject to all U.S. guidelines applicable to dispensing a prescription product.

Important LATISSE™ Safety Information LATISSE™ solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. DO NOT APPLY to the lower eyelid. If you are using LUMIGAN® or other products in the same class for elevated intraocular pressure (IOP), or if you have a history of abnormal IOP, you should only use LATISSE™ under the close supervision of your doctor.

LATISSE™ use may cause darkening of the eyelid skin which may be reversible. Although not reported in clinical studies, LATISSE™ use may also cause increased brown pigmentation of the colored part of the eye which is likely to be permanent.

It is possible for hair growth to occur in other areas of your skin that LATISSE™ frequently touches. Any excess solution outside the upper eyelid margin should be blotted with a tissue or other absorbent material to reduce the chance of this from happening. It is also possible for a difference in eyelash length, thickness, fullness, pigmentation, number of eyelash hairs, and/or direction of eyelash growth to occur between eyes. These differences, should they occur, will usually go away if you stop using LATISSE™.

The most common side effects after using LATISSE™ solution are an itching sensation in the eyes and/or eye redness. This was reported in approximately 4% of patients. LATISSE™ solution may cause other less common side effects which typically occur on the skin close to where LATISSE™ is applied, or in the eyes. These include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.

If you develop a new ocular condition (e.g., trauma or infection), experience a sudden decrease in visual acuity, have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions, you should immediately seek your doctor’s advice concerning the continued use of LATISSE™ solution.

Non-Invasive Services:
Botox
Soft Tissue Fillers
Chemical Peels
Microdermabrasion
Hair Removal
Laser
Eyelashes
Cosmetic Surgery Procedures:
Eyelid Surgery
Brow Lift
Face Lift
Facial Implants
Plastic Surgery Ohio
The Eye Center of Columbus
262 Neil Ave., Suite 410
Columbus, OH 43215
(614) 827-6712
Internet Contact

Conveniently located in the Arena District and Short North

Copyright© 2011
Powered by LKH.COM


Links:
BotoxInjectionsColumbus.Com
FacialFillersColumbus.Com
PlasticSurgeryOhio.Com
RestylaneInjectionsColumbus.Com
LipsEyelids.Com